Health Canada accepts New Drug Submission for lecanemab as treatment for early Alzheimer’s disease

STOCKHOLM, May 16, 2023 /PRNewswire/ —  BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Health Canada has accepted a New Drug Submission (NDS) for lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer’s disease[2] with confirmed amyloid pathology in the brain. … Read more

Clarification regarding announcement of senior management changes in SciBase

STOCKHOLM, May 16, 2023 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders hereby clarifies the May 15th announcement that Simon Grant will leave his position as CEO for personal reasons. Simon will transition out of his role over the next six months but will remain formally … Read more

Rising Incidence of Colorectal Cancer, Bladder Cancer, and IBD and Drives Growth

DUBLIN, May 15, 2023 /PRNewswire/ — The “Stoma/Ostomy Care: Global Strategic Business Report” report has been added to  ResearchAndMarkets.com’s offering. Global Stoma/Ostomy Care Products Market to Reach $5.1 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Stoma/Ostomy Care Products estimated at US$3.3 Billion in the year 2022, is projected to … Read more

LG Chem Targets Sixfold Sales Growth in Battery Materials to KRW 30 Trillion by 2030

– Will expand sales portion in battery materials, sustainability business and innovative new drugs – Aims to accelerate in reaching net zero by 2050 by proactively building an integrated low-carbon management system SEOUL, South Korea, May 15, 2023 /PRNewswire/ — LG Chem today announced its business strategy to leap up to become a top global battery … Read more

Smoking Cessation And Nicotine De-addiction Market size to grow by USD 24,529.75 million from 2022 to 2027, North America to account for 32% of the market growth

NEW YORK, May 15, 2023 /PRNewswire/ — The smoking cessation and nicotine de-addiction market size is estimated to grow by USD 24529.75 million during 2023-2027. However, the growth momentum will be progressing at a CAGR of 12.59% during the forecast period. The market is segmented by Distribution Channel (Drug stores and retailers, Hospital pharmacies, and Online retail), Product … Read more

GREENBROOK TMS REPORTS FIRST QUARTER OPERATIONAL AND FINANCIAL RESULTS

TORONTO, May 15, 2023 /PRNewswire/ – Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company“) today announced its first quarter 2023 (“Q1 2023“) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated. FIRST QUARTER 2023 OPERATIONAL AND FINANCIAL HIGHLIGHTS Quarterly revenue increased by 52% to $19.9 million, … Read more

Feminine Hygiene Wash Market size to grow by USD 121.55 million between 2022 and 2027; Advertising and promotion of feminine hygiene wash products identified as a key driver

NEW YORK, May 15, 2023 /PRNewswire/ — The latest report on the feminine hygiene wash market, 2023-2027 estimates to register an incremental growth of USD 121.55 million, accelerating at a CAGR of 5.26% during the forecast period. The market is fragmented due to the presence of diversified international and regional vendors. The growth of the feminine hygiene wash market is largely driven … Read more

VOXX International Corporation Reports its Fiscal 2023 Fourth Quarter and Year-End Financial Results

ORLANDO, Fla., May 15, 2023 /PRNewswire/ — VOXX International Corporation (NASDAQ: VOXX), a leading manufacturer and distributor of automotive and consumer technologies for the global markets, today announced its financial results for its Fiscal 2023 fourth quarter and full year ended February 28, 2023. Commenting on the Company’s results and business outlook, Pat Lavelle, Chief … Read more

Kodiak Sciences Announces First Quarter 2023 Financial Results and Recent Business Highlights

PALO ALTO, Calif., May 15, 2023 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today reported business highlights and financial results for the quarter ended March 31, 2023. “We are on the cusp of four Phase 3 study readouts … Read more

INVO Reports First Quarter 2023 Financial Results

Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., May 15, 2023 /PRNewswire/ — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture (“IVC”) procedure it enables, today announced financial results for … Read more